The Institutions for Mental Diseases Exclusion Rule is an Anachronism
The time has come for repealing Medicaid’s Institutions for Mental Diseases Exclusion rule.
Prescription Drug Affordability
The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.
Has the Supreme Court Endorsed the Use of Junk Science in the Administrative State?
A recent Supreme Court decision could allow courts to rely on dubious science.
Defining and Establishing Goals for Medicare for All
Although “Medicare for all” has picked up political traction, how it will materialize remains unclear.
What Tomorrow Holds for U.S. Health Care
Experts offer solutions to pressing issues in American health care.
Week in Review
The Supreme Court rules on class arbitration, the Department of State ends exemptions to Iran trade sanctions, and more…
Which of Trump’s Regulatory Reforms Are Likely to Last?
In its novel effort to bring independent agency regulations under White House oversight, the Trump Administration may have found a lasting legacy.
The Black Box of College Admissions
State legislators and the U.S. Education Department are scrutinizing college admissions practices.
Are Mutual Funds Bad for U.S. Consumers?
Regulators consider whether mutual funds’ common ownership of competing companies is bad for consumers.
Tribal Regulation of Single-Use Plastics
As the federal government and many state governments fail to address plastic waste, Indian tribes become policy innovators.
Poetry Inspires Hope and Climate Action
Poetry can help combat despair and act as a force for optimism and change.
Week in Review
Attorney General releases report on Russian election interference, EU approves online copyright laws, and more…